Abstract:Successful skin wound healing is dependent on an interplay between epidermal keratinocytes and dermal fibroblasts as they react to local extracellular factors (DAMPs, PAMPs, cytokines, etc.) surveyed from that environment by numerous membrane receptors (e.g., TLRs, cytokine receptors, etc.). In turn, those receptors are the start of a cytoplasmic signaling pathway where balance is key to effective healing and, as needed, cell and matrix regeneration. When directed through NF-κB, these signaling routes lead to transient responses to the benefit of initiating immune cell recruitment, cell replication, local chemokine and cytokine production, and matrix protein synthesis. The converse can also occur, where ongoing canonical NF-κB activation leads to chronic, hyper-responsive states. Here, we assess three key players, TAK1, TNFAIP3, and TNIP1, in cytoplasmic regulation of NF-κB activation, which, because of their distinctive and yet inter-related functions, either promote or limit that activation. Their balanced function is integral to successful wound healing, given their significant control over the expression of inflammation-, fibrosis-, and matrix remodeling-associated genes. Intriguingly, these three proteins have also been emphasized in dysregulated NF-κB signaling central to systemic sclerosis (SSc). Notably, diffuse SSc shares some tissue features similar to an excessive inflammatory/fibrotic wound response without eventual resolution. Taking a cue from certain instances of aberrant wound healing and SSc having some shared aspects, e.g., chronic inflammation and fibrosis, this review looks for the first time, to our knowledge, at what those pathologies might have in common regarding the cytoplasmic progression of NF-κB-mediated signaling. Additionally, while TAK1, TNFAIP3, and TNIP1 are often investigated and reported on individually, we propose them here as three proteins whose consequences of function are very highly interconnected at the signaling focus of NF-κB. We thus highlight the emerging promise for the eventual clinical benefit derived from an improved understanding of these integral signal progression modulators. Depending on the protein, its indirect or direct pharmacological regulation has been reported. Current findings support further intensive studies of these points in NF-κB regulation both for their basic function in healthy cells as well as with the goal of targeting them for translational benefit in multiple cutaneous wound healing situations, whether stemming from acute injury or a dysregulated inflammatory/fibrotic response.

JNK Signaling as a Key Modulator of Soft Connective Tissue Physiology, Pathology, and Healing

The role of JNK signaling pathway in organ fibrosis

The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer

A threshold level of JNK activates damage-responsive enhancers via JAK/STAT to promote tissue regeneration

The c-Jun NH2-terminal kinase is essential for epidermal growth factor expression during epidermal morphogenesis

JNK Signaling Pathway Involvement in Spinal Cord Neuron Development and Death

Mechanisms of c-Jun N-terminal kinase signal transduction pathway regulating cell migration

The JNK Signaling Pathway in Renal Fibrosis

The Role of the Dysregulated JNK Signaling Pathway in the Pathogenesis of Human Diseases and Its Potential Therapeutic Strategies: A Comprehensive Review

JNK signaling and its impact on neural cell maturation and differentiation

c-Jun N-terminal kinase 2 promotes enterocyte survival and goblet cell differentiation in the inflamed intestine

Activation of Jnk Signaling Mediates Connective Tissue Growth Factor Expression and Scar Formation in Corneal Wound Healing

The role of ERK and JNK signaling in connective tissue growth factor induced extracellular matrix protein production and scar formation

Critical Analysis of Cytoplasmic Progression of Inflammatory Signaling Suggests Potential Pharmacologic Targets for Wound Healing and Fibrotic Disorders

JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species

Two-Faced: Roles of JNK Signalling During Tumourigenesis in the Drosophila Model

Differential Roles of JNK, ERK1/2, and P38 Mitogen-Activated Protein Kinases on Endothelial Cell Tissue Repair Functions in Response to Tumor Necrosis Factor-α

c-Jun N-Terminal Kinases (JNKs) Are Critical Mediators of Osteoblast Activity In Vivo.

JNK signaling pathway and extracellular stimulations in ocular tissue

The Roles of c-Jun N-Terminal Kinase (JNK) in Infectious Diseases

c-Jun N-terminal kinase signaling in cellular senescence